[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Europe Ophthalmic Drug Market Report 2017

January 2017 | 117 pages | ID: E3C444440E4EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:


Sales, means the sales volume of Ophthalmic Drug

Revenue, means the sales value of Ophthalmic Drug

This report studies sales (consumption) of Ophthalmic Drug in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
  • Novartis
  • Allergan
  • Santen
  • Pfizer
  • Merck
  • Roche
  • Bayer
  • Senju
  • Regeneron
  • Valeant
  • Ozurdex
Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Ophthalmic Drug in these countries, from 2011 to 2021 (forecast), like
  • Germany
  • France
  • UK
  • Russia
  • Italy
  • Spain
  • Benelux
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Prescription Drugs
  • OTC Drugs
Split by application, this report focuses on sales, market share and growth rate of Ophthalmic Drug in each application, can be divided into
  • Dry Eye Drugs
  • Retinal Drugs
  • Infective Drugs
  • Others
Europe Ophthalmic Drug Market Report 2017

1 OPHTHALMIC DRUG OVERVIEW

1.1 Product Overview and Scope of Ophthalmic Drug
1.2 Classification of Ophthalmic Drug
  1.2.1 Prescription Drugs
  1.2.2 OTC Drugs
1.3 Application of Ophthalmic Drug
  1.3.1 Dry Eye Drugs
  1.3.2 Retinal Drugs
  1.3.3 Infective Drugs
  1.3.4 Others
1.4 Ophthalmic Drug Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Ophthalmic Drug (2011-2021)
  1.5.1 Europe Ophthalmic Drug Sales and Growth Rate (2011-2021)
  1.5.2 Europe Ophthalmic Drug Revenue and Growth Rate (2011-2021)

2 EUROPE OPHTHALMIC DRUG BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Ophthalmic Drug Market Competition by Manufacturers
  2.1.1 Europe Ophthalmic Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Ophthalmic Drug Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Ophthalmic Drug (Volume and Value) by Type
  2.2.1 Europe Ophthalmic Drug Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Ophthalmic Drug Revenue and Market Share by Type (2011-2016)
2.3 Europe Ophthalmic Drug (Volume and Value) by Countries
  2.3.1 Europe Ophthalmic Drug Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Ophthalmic Drug Revenue and Market Share by Countries (2011-2016)
2.4 Europe Ophthalmic Drug (Volume) by Application

3 GERMANY OPHTHALMIC DRUG (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Ophthalmic Drug Sales and Value (2011-2016)
  3.1.1 Germany Ophthalmic Drug Sales and Growth Rate (2011-2016)
  3.1.2 Germany Ophthalmic Drug Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Ophthalmic Drug Sales Price Trend (2011-2016)
3.2 Germany Ophthalmic Drug Sales and Market Share by Manufacturers
3.3 Germany Ophthalmic Drug Sales and Market Share by Type
3.4 Germany Ophthalmic Drug Sales and Market Share by Application

4 FRANCE OPHTHALMIC DRUG (VOLUME, VALUE AND SALES PRICE)

4.1 France Ophthalmic Drug Sales and Value (2011-2016)
  4.1.1 France Ophthalmic Drug Sales and Growth Rate (2011-2016)
  4.1.2 France Ophthalmic Drug Revenue and Growth Rate (2011-2016)
  4.1.4 France Ophthalmic Drug Sales Price Trend (2011-2016)
4.2 France Ophthalmic Drug Sales and Market Share by Manufacturers
4.3 France Ophthalmic Drug Sales and Market Share by Type
4.4 France Ophthalmic Drug Sales and Market Share by Application

5 UK OPHTHALMIC DRUG (VOLUME, VALUE AND SALES PRICE)

5.1 UK Ophthalmic Drug Sales and Value (2011-2016)
  5.1.1 UK Ophthalmic Drug Sales and Growth Rate (2011-2016)
  5.1.2 UK Ophthalmic Drug Revenue and Growth Rate (2011-2016)
  5.1.5 UK Ophthalmic Drug Sales Price Trend (2011-2016)
5.2 UK Ophthalmic Drug Sales and Market Share by Manufacturers
5.3 UK Ophthalmic Drug Sales and Market Share by Type
5.4 UK Ophthalmic Drug Sales and Market Share by Application

6 RUSSIA OPHTHALMIC DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Ophthalmic Drug Sales and Value (2011-2016)
  6.1.1 Russia Ophthalmic Drug Sales and Growth Rate (2011-2016)
  6.1.2 Russia Ophthalmic Drug Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Ophthalmic Drug Sales Price Trend (2011-2016)
6.2 Russia Ophthalmic Drug Sales and Market Share by Manufacturers
6.3 Russia Ophthalmic Drug Sales and Market Share by Type
6.4 Russia Ophthalmic Drug Sales and Market Share by Application

7 ITALY OPHTHALMIC DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Ophthalmic Drug Sales and Value (2011-2016)
  7.1.1 Italy Ophthalmic Drug Sales and Growth Rate (2011-2016)
  7.1.2 Italy Ophthalmic Drug Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Ophthalmic Drug Sales Price Trend (2011-2016)
7.2 Italy Ophthalmic Drug Sales and Market Share by Manufacturers
7.3 Italy Ophthalmic Drug Sales and Market Share by Type
7.4 Italy Ophthalmic Drug Sales and Market Share by Application

8 SPAIN OPHTHALMIC DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Ophthalmic Drug Sales and Value (2011-2016)
  8.1.1 Spain Ophthalmic Drug Sales and Growth Rate (2011-2016)
  8.1.2 Spain Ophthalmic Drug Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Ophthalmic Drug Sales Price Trend (2011-2016)
8.2 Spain Ophthalmic Drug Sales and Market Share by Manufacturers
8.3 Spain Ophthalmic Drug Sales and Market Share by Type
8.4 Spain Ophthalmic Drug Sales and Market Share by Application

9 BENELUX OPHTHALMIC DRUG (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Ophthalmic Drug Sales and Value (2011-2016)
  9.1.1 Benelux Ophthalmic Drug Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Ophthalmic Drug Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Ophthalmic Drug Sales Price Trend (2011-2016)
9.2 Benelux Ophthalmic Drug Sales and Market Share by Manufacturers
9.3 Benelux Ophthalmic Drug Sales and Market Share by Type
9.4 Benelux Ophthalmic Drug Sales and Market Share by Application

10 EUROPE OPHTHALMIC DRUG MANUFACTURERS ANALYSIS

10.1 Novartis
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Ophthalmic Drug Product Type, Application and Specification
    10.1.2.1 Prescription Drugs
    10.1.2.2 OTC Drugs
  10.1.3 Novartis Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Allergan
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Ophthalmic Drug Product Type, Application and Specification
    10.2.2.1 Prescription Drugs
    10.2.2.2 OTC Drugs
  10.2.3 Allergan Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Santen
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Ophthalmic Drug Product Type, Application and Specification
    10.3.2.1 Prescription Drugs
    10.3.2.2 OTC Drugs
  10.3.3 Santen Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Pfizer
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Ophthalmic Drug Product Type, Application and Specification
    10.4.2.1 Prescription Drugs
    10.4.2.2 OTC Drugs
  10.4.3 Pfizer Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Merck
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Ophthalmic Drug Product Type, Application and Specification
    10.5.2.1 Prescription Drugs
    10.5.2.2 OTC Drugs
  10.5.3 Merck Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Roche
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Ophthalmic Drug Product Type, Application and Specification
    10.6.2.1 Prescription Drugs
    10.6.2.2 OTC Drugs
  10.6.3 Roche Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Bayer
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Ophthalmic Drug Product Type, Application and Specification
    10.7.2.1 Prescription Drugs
    10.7.2.2 OTC Drugs
  10.7.3 Bayer Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 Senju
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Ophthalmic Drug Product Type, Application and Specification
    10.8.2.1 Prescription Drugs
    10.8.2.2 OTC Drugs
  10.8.3 Senju Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview
10.9 Regeneron
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Ophthalmic Drug Product Type, Application and Specification
    10.9.2.1 Prescription Drugs
    10.9.2.2 OTC Drugs
  10.9.3 Regeneron Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.9.4 Main Business/Business Overview
10.10 Valeant
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Ophthalmic Drug Product Type, Application and Specification
    10.10.2.1 Prescription Drugs
    10.10.2.2 OTC Drugs
  10.10.3 Valeant Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  10.10.4 Main Business/Business Overview
10.11 Ozurdex

11 OPHTHALMIC DRUG MANUFACTURING COST ANALYSIS

11.1 Ophthalmic Drug Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Ophthalmic Drug

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Ophthalmic Drug Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Ophthalmic Drug Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE OPHTHALMIC DRUG MARKET FORECAST (2016-2021)

14.1 Germany Ophthalmic Drug Sales Forecast (2016-2021)
14.2 France Ophthalmic Drug Sales Forecast (2016-2021)
14.3 UK Ophthalmic Drug Sales Forecast (2016-2021)
14.4 Russia Ophthalmic Drug Sales Forecast (2016-2021)
14.5 Italy Ophthalmic Drug Sales Forecast (2016-2021)
14.6 Spain Ophthalmic Drug Sales Forecast (2016-2021)
14.7 Benelux Ophthalmic Drug Sales Forecast (2016-2021)
14.8 Europe Ophthalmic Drug Sales Forecast by Type (2016-2021)
14.9 Europe Ophthalmic Drug Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Ophthalmic Drug
Table Classification of Ophthalmic Drug
Figure Europe Sales Market Share of Ophthalmic Drug by Type in 2015
Figure Prescription Drugs Picture
Figure OTC Drugs Picture
Table Application of Ophthalmic Drug
Figure Europe Sales Market Share of Ophthalmic Drug by Application in 2015
Figure Dry Eye Drugs Examples
Figure Retinal Drugs Examples
Figure Infective Drugs Examples
Figure Others Examples
Figure Germany Ophthalmic Drug Revenue and Growth Rate (2011-2021)
Figure France Ophthalmic Drug Revenue and Growth Rate (2011-2021)
Figure UK Ophthalmic Drug Revenue and Growth Rate (2011-2021)
Figure Russia Ophthalmic Drug Revenue and Growth Rate (2011-2021)
Figure Italy Ophthalmic Drug Revenue and Growth Rate (2011-2021)
Figure Spain Ophthalmic Drug Revenue and Growth Rate (2011-2021)
Figure Benelux Ophthalmic Drug Revenue and Growth Rate (2011-2021)
Figure Europe Ophthalmic Drug Sales and Growth Rate (2011-2021)
Figure Europe Ophthalmic Drug Revenue and Growth Rate (2011-2021)
Table Europe Ophthalmic Drug Sales of Key Manufacturers (2015 and 2016)
Table Europe Ophthalmic Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Ophthalmic Drug Sales Share by Manufacturers
Figure 2016 Ophthalmic Drug Sales Share by Manufacturers
Table Europe Ophthalmic Drug Revenue by Manufacturers (2015 and 2016)
Table Europe Ophthalmic Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Ophthalmic Drug Revenue Share by Manufacturers
Table 2016 Europe Ophthalmic Drug Revenue Share by Manufacturers
Table Europe Ophthalmic Drug Sales and Market Share by Type (2011-2016)
Table Europe Ophthalmic Drug Sales Share by Type (2011-2016)
Figure Sales Market Share of Ophthalmic Drug by Type (2011-2016)
Figure Europe Ophthalmic Drug Sales Growth Rate by Type (2011-2016)
Table Europe Ophthalmic Drug Revenue and Market Share by Type (2011-2016)
Table Europe Ophthalmic Drug Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Ophthalmic Drug by Type (2011-2016)
Figure Europe Ophthalmic Drug Revenue Growth Rate by Type (2011-2016)
Table Europe Ophthalmic Drug Sales and Market Share by Countries (2011-2016)
Table Europe Ophthalmic Drug Sales Share by Countries (2011-2016)
Figure Sales Market Share of Ophthalmic Drug by Countries (2011-2016)
Table Europe Ophthalmic Drug Revenue and Market Share by Countries (2011-2016)
Table Europe Ophthalmic Drug Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Ophthalmic Drug by Countries (2011-2016)
Table Europe Ophthalmic Drug Sales and Market Share by Application (2011-2016)
Table Europe Ophthalmic Drug Sales Share by Application (2011-2016)
Figure Sales Market Share of Ophthalmic Drug by Application (2011-2016)
Figure Germany Ophthalmic Drug Sales and Growth Rate (2011-2016)
Figure Germany Ophthalmic Drug Revenue and Growth Rate (2011-2016)
Figure Germany Ophthalmic Drug Sales Price Trend (2011-2016)
Table Germany Ophthalmic Drug Sales by Manufacturers (2015 and 2016)
Table Germany Ophthalmic Drug Market Share by Manufacturers (2015 and 2016)
Table Germany Ophthalmic Drug Sales by Type (2015 and 2016)
Table Germany Ophthalmic Drug Market Share by Type (2015 and 2016)
Table Germany Ophthalmic Drug Sales by Application (2015 and 2016)
Table Germany Ophthalmic Drug Market Share by Application (2015 and 2016)
Figure France Ophthalmic Drug Sales and Growth Rate (2011-2016)
Figure France Ophthalmic Drug Revenue and Growth Rate (2011-2016)
Figure France Ophthalmic Drug Sales Price Trend (2011-2016)
Table France Ophthalmic Drug Sales by Manufacturers (2015 and 2016)
Table France Ophthalmic Drug Market Share by Manufacturers (2015 and 2016)
Table France Ophthalmic Drug Sales by Type (2015 and 2016)
Table France Ophthalmic Drug Market Share by Type (2015 and 2016)
Table France Ophthalmic Drug Sales by Application (2015 and 2016)
Table France Ophthalmic Drug Market Share by Application (2015 and 2016)
Figure UK Ophthalmic Drug Sales and Growth Rate (2011-2016)
Figure UK Ophthalmic Drug Revenue and Growth Rate (2011-2016)
Figure UK Ophthalmic Drug Sales Price Trend (2011-2016)
Table UK Ophthalmic Drug Sales by Manufacturers (2015 and 2016)
Table UK Ophthalmic Drug Market Share by Manufacturers (2015 and 2016)
Table UK Ophthalmic Drug Sales by Type (2015 and 2016)
Table UK Ophthalmic Drug Market Share by Type (2015 and 2016)
Table UK Ophthalmic Drug Sales by Application (2015 and 2016)
Table UK Ophthalmic Drug Market Share by Application (2015 and 2016)
Figure Russia Ophthalmic Drug Sales and Growth Rate (2011-2016)
Figure Russia Ophthalmic Drug Revenue and Growth Rate (2011-2016)
Figure Russia Ophthalmic Drug Sales Price Trend (2011-2016)
Table Russia Ophthalmic Drug Sales by Manufacturers (2015 and 2016)
Table Russia Ophthalmic Drug Market Share by Manufacturers (2015 and 2016)
Table Russia Ophthalmic Drug Sales by Type (2015 and 2016)
Table Russia Ophthalmic Drug Market Share by Type (2015 and 2016)
Table Russia Ophthalmic Drug Sales by Application (2015 and 2016)
Table Russia Ophthalmic Drug Market Share by Application (2015 and 2016)
Figure Italy Ophthalmic Drug Sales and Growth Rate (2011-2016)
Figure Italy Ophthalmic Drug Revenue and Growth Rate (2011-2016)
Figure Italy Ophthalmic Drug Sales Price Trend (2011-2016)
Table Italy Ophthalmic Drug Sales by Manufacturers (2015 and 2016)
Table Italy Ophthalmic Drug Market Share by Manufacturers (2015 and 2016)
Table Italy Ophthalmic Drug Sales by Type (2015 and 2016)
Table Italy Ophthalmic Drug Market Share by Type (2015 and 2016)
Table Italy Ophthalmic Drug Sales by Application (2015 and 2016)
Table Italy Ophthalmic Drug Market Share by Application (2015 and 2016)
Figure Spain Ophthalmic Drug Sales and Growth Rate (2011-2016)
Figure Spain Ophthalmic Drug Revenue and Growth Rate (2011-2016)
Figure Spain Ophthalmic Drug Sales Price Trend (2011-2016)
Table Spain Ophthalmic Drug Sales by Manufacturers (2015 and 2016)
Table Spain Ophthalmic Drug Market Share by Manufacturers (2015 and 2016)
Table Spain Ophthalmic Drug Sales by Type (2015 and 2016)
Table Spain Ophthalmic Drug Market Share by Type (2015 and 2016)
Table Spain Ophthalmic Drug Sales by Application (2015 and 2016)
Table Spain Ophthalmic Drug Market Share by Application (2015 and 2016)
Figure Benelux Ophthalmic Drug Sales and Growth Rate (2011-2016)
Figure Benelux Ophthalmic Drug Revenue and Growth Rate (2011-2016)
Figure Benelux Ophthalmic Drug Sales Price Trend (2011-2016)
Table Benelux Ophthalmic Drug Sales by Manufacturers (2015 and 2016)
Table Benelux Ophthalmic Drug Market Share by Manufacturers (2015 and 2016)
Table Benelux Ophthalmic Drug Sales by Type (2015 and 2016)
Table Benelux Ophthalmic Drug Market Share by Type (2015 and 2016)
Table Benelux Ophthalmic Drug Sales by Application (2015 and 2016)
Table Benelux Ophthalmic Drug Market Share by Application (2015 and 2016)
Table Ophthalmic Drug Basic Information List
Table Novartis Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Ophthalmic Drug Sales Market Share (2011-2016)
Table Allergan Basic Information List
Table Allergan Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Allergan Ophthalmic Drug Sales Market Share (2011-2016)
Table Santen Basic Information List
Table Santen Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Santen Ophthalmic Drug Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Ophthalmic Drug Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Ophthalmic Drug Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Ophthalmic Drug Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Ophthalmic Drug Sales Market Share (2011-2016)
Table Senju Basic Information List
Table Senju Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Senju Ophthalmic Drug Sales Market Share (2011-2016)
Table Regeneron Basic Information List
Table Regeneron Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Regeneron Ophthalmic Drug Sales Market Share (2011-2016)
Table Valeant Basic Information List
Table Valeant Ophthalmic Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Valeant Ophthalmic Drug Sales Market Share (2011-2016)
Table Ozurdex Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ophthalmic Drug
Figure Manufacturing Process Analysis of Ophthalmic Drug
Figure Ophthalmic Drug Industrial Chain Analysis
Table Raw Materials Sources of Ophthalmic Drug Major Manufacturers in 2015
Table Major Buyers of Ophthalmic Drug
Table Distributors/Traders List
Figure Germany Ophthalmic Drug Sales and Growth Rate Forecast (2016-2021)
Figure Germany Ophthalmic Drug Revenue and Growth Rate Forecast (2016-2021)
Figure France Ophthalmic Drug Sales and Growth Rate Forecast (2016-2021)
Figure France Ophthalmic Drug Revenue and Growth Rate Forecast (2016-2021)
Figure UK Ophthalmic Drug Sales and Growth Rate Forecast (2016-2021)
Figure UK Ophthalmic Drug Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Ophthalmic Drug Sales and Growth Rate Forecast (2016-2021)
Figure Russia Ophthalmic Drug Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Ophthalmic Drug Sales and Growth Rate Forecast (2016-2021)
Figure Italy Ophthalmic Drug Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Ophthalmic Drug Sales and Growth Rate Forecast (2016-2021)
Figure Spain Ophthalmic Drug Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Ophthalmic Drug Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Ophthalmic Drug Revenue and Growth Rate Forecast (2016-2021)
Table Europe Ophthalmic Drug Sales Forecast by Type (2016-2021)
Table Europe Ophthalmic Drug Sales Forecast by Application (2016-2021)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories